The searchable archive below contains a list of Knight ADRC Tuesday Seminar presenters, the date of their presentation, institutional affiliation, and the title of their talk. The archive starts in 2000 with listings displayed in reverse chronological order (most recent first). Note that prior to 2020, some events may be missing or inaccurate due to last minute changes/cancellations.

Total Entries: 1332


 

DatePresenterAffiliationTitle
September 17, 2013David Beebe, PhD

WashU

Using the Eye to Look for Alzheimer’s Disease
September 10, 2013Niki Armstrong, MS, CGC

WashU

Genetic Counseling and Testing for Autosomal Dominant Alzheimer Disease
September 3, 2013Rachel Chasse, BA & David Ruvolo, MSG

WashU

AD Biomarkers and Normative Cognitive Data: the SuperNorms Approach | Attenuation of Practice Effects on Neuropsychological Performance is a Potential Marker of Preclinical Alzheimer’s Disease
August 27, 2013Aarti Shah, BA

WashU

Evaluation of Pre-Analytical and Analytical Factors that Contribute to Variability in CSF Biomarker Levels
August 20, 2013Suzanne Schindler, MD, PhD

WashU

TBA
August 13, 2013Matthew Brier, BA

WashU

TBA
August 6, 2013John M. Beale, Jr., PhD

Saint Louis College of Pharmacy

TBA
July 30, 2013Abhinav Diwan, MD, FACC, FAHA

WashU

Enhancing Lysosome Biogenesis to Attenuate Amyloid Plaque Pathogenesis
July 23, 2013Carlos Cruchaga. PhD, Jason Hassenstab, PhD, and Matthew Brier, BA

WashU

Alzheimer’s Association International Conference Overview
July 16, 2013No Seminar

AAIC
July 9, 2013No Seminar

AAIC Poster Session
July 2, 2013Brian A. Gordon, PhD

WashU

Alterations in fMRI Activity Associated with CSF Biomarkers
June 25, 2013Andrea Denny, JD, MSSW and Jennifer K. Phillips, MPA

WashU

The Dementia Understanding Opportunity (DUO) Program One Year Later
June 18, 2013John C. Morris, MD

WashU

State of the Knight ADRC
June 11, 2013Sarah DeVos, BS

WashU

Targeting Tau as a Treatment for Neurodegeneration
June 4, 2013Jan Duchek, PhD

WashU

Lifestyle and personality measures as markers for early stage AD and predictors for AD
May 28, 2013Cathy C. Sarli, MLS, AHIP

WashU

NIH Public Access Policy
May 21, 2013Susan L. Mills & Anna M. Santacruz

WashU

The Dominantly Inherited Alzheimer’s Network Trials Unit: AD Prevention Trials
May 14, 2013Rebecca Dresser, JD

WashU

Paternalism vs. Partnership in Clinical Research
May 7, 2013Joe Cheung, MD; Esther Hsiao, MD; Davis Ryman, MD, PhD; Cindy Ly, MD, PhD

WashU

Neurology Residents’ Seminar
April 30, 2013Gregory Day, MD, MSc

University of Toronto

Exploring Inflammatory Brain Disease through the Eyes of a Cognitive Neurologist
April 23, 2013No Seminar

Hope Center Retreat
April 16, 2013Shannon MacCauly Rambach

WashU

TBA
April 9, 2013Marco Colonna, MD

WashU

Innate Lymphoid Cells in Mucosal Immunity
April 2, 2013Andrei Vlassenko, MD, PhD

WashU

PIB Accumulation in Early Stages of Preclinical AD